FDA Approves Rapid-acting insulin lispro-aabc Injection for Pump Therapy
Previously Published on Healio.com – The FDA approved an expanded label for rapid-acting insulin lispro-aabc injection to include administration via continuous subcutaneous infusion with an insulin pump, according to an industry press release. As Healio previously reported, insulin lispro-aabc injection (Lyumjev, Eli Lilly), a novel formulation of insulin lispro developed to speed the absorption of…